EPH131 Estimation of the Population of Patients Eligible for Pirtobrutinib after Covalent Bruton Tyrosine Kinase Inhibitor (CBTKI) Discontinuation in the United States

Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1013
https://www.valueinhealthjournal.com/article/S1098-3015(23)01113-0/fulltext
Title : EPH131 Estimation of the Population of Patients Eligible for Pirtobrutinib after Covalent Bruton Tyrosine Kinase Inhibitor (CBTKI) Discontinuation in the United States
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01113-0&doi=10.1016/j.jval.2023.03.1013
First page :
Section Title :
Open access? : No
Section Order : 10458
Categories :
Tags :
Regions :
ViH Article Tags :